Nalu Medical, Inc. Announces $65 Million Equity Financing To Advance Treatment For Chronic Neuropathic Pain

Jan 03, 2024•almost 2 years ago

Amount Raised

$65 Million

CarlsbadMedical DeviceMedicalBiotechnologyHealth Care

Investors

Aperture Venture PartnersPura VidaAdvent Life SciencesLongitude CapitalDecheng CapitalEndeavor VisionMvm PartnersGilde HealthcareNovo Holdings

Description

Nalu Medical Inc. (Nalu), a private company focused on innovative, minimally invasive, and non-opioid solutions for chronic neuropathic pain, announced today the closing of a $65 million equity financing. The round was led by a new investor, Novo Holdings (Novo). Also participating in the round were all of the Nalu existing significant investors: Gilde Healthcare, MVM Partners, Endeavor Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida, and Aperture Venture Partners

Company Information

Company

Nalu Medical

Location

Carlsbad, California, United States

About

Nalu is a Carlsbad, California-based medical technology company focused on developing and commercializing innovative and minimally invasive solutions for patients with chronic neuropathic pain. The Nalu Neurostimulation System delivers gentle electrical pulses to the nervous system to modulate pain signals before they get to the brain. The Nalu System was designed to address major unmet needs in the treatment of chronic neuropathic pain and provide a differentiated value proposition for patients and physicians.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends